Bioxodes
Bioxodes is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of therapeutics for patients with thrombo-inflammatory diseases. We leverage our deep understanding of the thrombotic and inflammatory processes to design novel product candidates with an aim to address unmet medical needs.
7-day free trial · no credit card
Verified contacts
13
available on Kipplo
LinkedIn employees
12
1 to 10 range
Open roles
—
no listings
Distinct roles
13
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 13 verified contacts at Bioxodes
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
13 contacts with verified email or phone · masked until revealed.
- CH
Cindy Hespel
Regulatory Affairs Manager · Legal
EmailPhone - SJ
Sebastien Jacobs
Finance Manager · Finance & Accounting
EmailPhone - VN
Victoria Nicolo
Assistante De Direction · General Business & Management
EmailPhone - CC
Charlotte Corbisier
- É · Other
EmailPhone - HW
Hans Warrinnier
Chief Medical Officer · Other
EmailPhone - MD
Marc Dechamps
(-) - · Other
EmailPhone - RA
Raphaël Avanzato
Head of Finance · Finance & Accounting
EmailPhone - SD
Sandrine Derochette
É È () · Other
EmailPhone - SD
Stéphanie Demoulin
É È · Other
EmailPhone
Showing 9 of 13 verified contacts
Top roles at Bioxodes
13 distinct titles indexed · top 10 shown.
- 1(-) -
- 1- é
- 1assistante de direction
- 1chief medical officer
- 1chief operating & scientific officer (coo & cso)
- 1finance manager
- 1head of finance
- 1preclinical operations manager & clinical data reviewer
- 1regulatory affairs manager
- 1senior project manager
- +3more titles
Sign up to unlock all 13 contacts at Bioxodes
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 13 verified contacts at Bioxodes
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.